BUZZ-Sartorius shares rise after report of Elliott investment

Bio-Rad Laboratories, Inc. Class A
Leverage Shares 2X Long SATS Daily ETF

Bio-Rad Laboratories, Inc. Class A

BIO

0.00

Leverage Shares 2X Long SATS Daily ETF

SATG

0.00

** Shares in Sartorius SATG_p.DE are up 2% after the Wall Street Journal reported that activist investor Elliott Investment Management had built a stake in the biopharma equipment supplier

** Elliott is also reported to have built a "significant" stake in Bio-Raad Laboratories, which UBS says owns 28% of Sartorius

** The WSJ said Elliott is planning to push Bio-Rad to improve its underperforming stock price and unlock value from Sartorius

** Elliott believes Sartorius is a high-quality business with strong growth prospects, WSJ said

** Sartorius sits atop the German midcap index .MDAXI, which is down 1.2%

** Shares in subsidiary Sartorius Stedim Biotech STDM.PA up 0.5%, above the wider SPF 120 Index .SBF120, which is down 1.1%


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.